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Summary
chromosome 17 (Kelly and Trowsdale, 1994; Radley et
al., 1994). Endosomal migration and retention of H2-M
H2-M (HLA-DM in humans) resides in an acidic endo- are mediated by a motif in the cytoplasmic tail of the b
somal compartment, where it facilitates the loading of chain. In the absence of this motif, H2-M/HLA-DM still
antigenic peptides into the peptide-binding groove of migrates to the loading compartment under the influ-
class II MHC. The crystal structure of a soluble form ence of Ii (Lindstedt et al., 1995; Copier et al., 1996). In
of H2-M has been solved to 3.1 AÊ resolution, revealing mice in which the H2-M a gene has been knocked out,
a heterodimer with structural similarities to the MHC class II MHC surface expression is reduced and the
family of proteins. In contrast to its antigen-presenting majority of these class II molecules are occupied with
cousins, the membrane distal a helices of H2-M pack CLIP (Fung-Leung et al., 1996; Miyazaki et al., 1996). A
closely together, occluding most of the binding groove similar phenotype is seen in human APC lines deficient
except for a single large pocket near the center. The for either of the HLA-DM chains (Denzin et al., 1994;
structure of H2-M has several unique features that may Morris et al., 1994). Both natural and recombinant HLA-
play a role in its function as a molecular chaperone and DM have been shown in vitro to facilitate the loading of
peptide exchange factor. peptides into empty or CLIP-containing human class II
MHC molecules at low pH (Sloan et al., 1995; Denzin et
Introduction al., 1996).
These studies favor the idea that H2-M/HLA-DM stabi-
Formation of the antigenic ligand recognized by the ab lizes an ªopenº conformation of class II MHC, a confor-
receptor (abTCR) of CD41 T cells involves a complex mation that allows rapid association and dissociation
pathway known as ªantigen processingº (reviewed in of peptides (Sloan et al., 1995; Denzin et al., 1996). Fur-
Unanue, 1992; Bertolino and Rabourdin-Combe, 1996; ther, it is thought that interaction is disfavored with class
Busch and Mellins,1996;Green and Pierce,1996;Weenink II that has strongly bound a peptide in a ªclosed,º stable
and Gautam, 1997). The end product of this pathway is configuration. Thus, in a milieu of peptides competing
a peptide, derived from antigen, bound to a specialized for class II binding, H2-M/HLA-DM reduces the time to
groove on one of the class II major histocompatibility equilibrium and promotes the strongest binding pep-
tides. In addition to interacting with class II MHC and
Ii, H2-M is also known to associate with H2-O (HLA-DO7 To whom correspondence should be addressed (e-mail: fremont@
immunology.wustl.edu). in humans), a conserved class II MHC±like molecule
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Table 1. Summary of Crystallographic Analysis
Multiple Isomorphous Replacement Native K2PtCl4 Thimerosal EMC SeMet
Resolution (AÊ ) 20.0±3.1 20.0±3.5 20.0±3.5 20.0±3.5 20.0±3.5
Number of sites Ð 1 1 1 5
Reflections measured 63314 35393 15744 24300 44671
(unique) (13888) (9602) (7589) (9217) (9655)
Completeness overall 98.1 97.6 77.1 93.6 98.1
(outer shell) (95.2) (85.2) (72.5) (88.0) (98.8)
I/s (I) overall 16.2 12.3 7.5 10.8 11.6
(outer shell) (1.71) (2.6) (1.7) (2.3) (2.6)
Rsym (%) overall 9.1 9.4 11.0 9.5 10.5
(outer shell) (48.2) (34.4) (35.6) (27.2) (32.7)
Riso (%) overall Ð 12.7 23.2 26.0 20.7
(outer shell) (34.0) (40.4) (41.0) (29.2)
Rcullis (to 5 AÊ ) centric/acentric Ð 0.84/0.83 0.86/0.82 0.87/0.86 0.83/0.81
Phasing power (to 5 AÊ ) centric/acentric Ð 0.89/0.46 0.86/0.69 0.85/0.62 1.01/0.53
Mean figure of merit acentric 0.48
centric 0.76
all 0.50
Number of Rms Deviations
Resolution Reflections Total Number
Refinement Range (AÊ ) (F . 0) of Atoms Rcrystal/Rfree (%) Bonds (AÊ ) Angles (Deg.)
Overall 12.0±3.1 13711 2963 20.5/25.6 0.009 1.9
(Outer shell) (3.2±3.1) (1303) (34.5/33.4)
Rsym (%) 5 100 3 S|I2,I. |/SI, where I is the integrated intensity of a given reflection.
Riso(%) 5 100 3 S | FPH | 2 |Fp|/S|Fp|, where FPH and FP are the derivative and native structure factor amplitudes, respectively.
Rcullis 5 S|FPH 6 FP| 2 |FH, calc|/S|FPH 6 FP|.
Phasing Power 5 S|FPH(calc)|2/(S|FPH(obs)2FP(calc)|2)1/2.
Figure of Merit 5 ,|SP(a)eia/S|P(a)|., where a is the phase and P(a) is the phase probability distribution.
Free Rfactor was calculated with 5% of the data.
expressed in a subset of APCs. H2-O is thought to nega- in which selenomethionine (SeMet) had been substi-
tuted for methionine. The structure was solved to a reso-tively regulate the H2-M catalyzed loading of peptides
onto class II MHC (Denzin et al., 1997; Liljedahl et al., lution of 3.1 AÊ by the combination of molecular replace-
ment and MIR. Details of the crystallizations, formation1998).
To learn which structural features of H2-M might be of derivatives, and structural determination are given
in the Experimental Procedures and summarized inimportant in its function, we have obtained the crystal
structure of a soluble version of the protein produced Table 1.
in baculovirus-infected cells. The 3.1 AÊ structure reveals
a class II MHC±like protein in which segments of the a Comparison of H2-M to Other MHC
and MHC-Like Moleculeshelices of the a1/b1-domains are packed close together,
precluding a conventional antigen-binding groove yet Figure 1A shows a ribbon diagram of theH2-M structure.
It has four domains, similar to those found in other MHCstill maintaining a single deep pocket. While the sites
of interaction between H2-M and its partners are not and MHC-like molecules. The membrane proximal a2 and
b2 domains both have immunoglobulin-like folds andimmediately obvious from the structure, several promi-
nent surface features are worth noting as they may play interact with standard geometry. The a1 and b1 domains
combine to form two antiparallel a helices lying on ana role in H2-M function.
eight-strand antiparallel b-sheet platform. A disulfide
bond conserved in all previously described MHC mole-Results and Discussion
cules is present in H2-M as well, occurring between the
s1 b strand and h2b a helix of the b1 domain, (Cys b10Production, Crystallization, and Structure
Determination of Soluble H2-M to Cys b78). There are two additional disulfide bonds
present in H2-M that do not occur in other MHC mole-The genes encoding the predicted luminal a1a2 do-
mains of the H2-M a chain and the b1b2 domains of the cules. One is in the a1 domain (Cys a21 and a76) at a
position symmetrical to the universal disulfide found inH2-M b2 chain were synthesized by PCR from cDNA of
C57BL/10 mice and cloned into baculovirus. Secreted, the class II MHC b1 domain and the analogous a2 do-
main of class I MHC. The second unique disulfide bondsoluble H2-M was purified to near homogeneity by the
combination of Con A Sepharose, size exclusion, and is in the b1 domain between b strands s2 and s3 (Cys
b24 and b34). These two additional disulfide bonds mayion exchange chromatography. Diffraction quality H2-M
crystals were grown in hanging drops containing 100 service to increase the stability of H2-M compared to
other MHC molecules. A surface-exposed free cysteinemM Li2SO4 and 100 mM MES at pH 5.5. Diffraction data
were obtained from crystals of the native protein, from (Cys b45), which sits immediately adjacent to Cys b34,
also is shown in Figure 1A. Based on the distancescrystal derivatives formed with several heavy metal
compounds, and also from crystals made using protein between the sulfur atoms, the possibility exists for Cys
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Figure 1. The Mouse H2-M Structure
(A) The overall fold and secondary structure
elements of H2-M are rendered as a ribbon
diagram (Carson, 1987). The H2-M a chain is
displayed in cyan and b chain in magenta.
For both chains, the b strand and a2helical
segments (Kabsch and Sander, 1983) are la-
beled. The two sites of N-linked carbohydrate
on the H2-M a chain are both displayed in
gray with full atomic positions for the GlcNAc
residues attached to Asn a12 and Asn a162.
All five disulfide bonds in the H2-M molecule
are schematically displayed in yellow and la-
beled, as is the free Cys b45.
(B) The overall structure of H2-M is compared
to IEk. The H2-M a chain is displayed in cyan
and b chain in magenta, while both the a and
b chainsof IEk are shown in gray. The disulfide
bonds and free cysteine of both molecules
are schematically displayed and the N- and
C-terminal residues of H2-M are labeled. In
this view, a peptide bound to IEk would have
its N-terminal residue on the right-hand side.
The two molecules were superimposed based
on residues in their b-sheet platforms (H22M
positions a13-a22, a28-a34, a37-a42, a48-
a51, b3-b12, b18-b27, b32-b36, b41-b44; IEk
positions a5-a14, a20-a26, a29-a34, a40-
a43, b8-b17, b23-b32, b37-b41, b46-b49).
Despite the highly divergent sequence and
function of these two molecules, the quater-
nary structuralarrangements of their domains
are extremely conserved.
(C) Trace comparison of the binding groove
regions of H2-M with an MHC class I (H2-Kb)
and class II (IEk) molecule. The Ca trace of
the a1 domain and b1 domain of H2-M are
shown in cyan and magenta, respectively.
The peptide-binding platform of H2-Kb and an eight-amino acid peptide from ovalbumin are shown in white. The peptide-binding platform of
IEk and a thirteen-amino acid peptide segment of hemoglobin are shown in gray. The peptide N2 and C-terminal regions are labeled, as are
the individual domains. Compared to the classic peptide-binding MHC molecules, both the a1 domain and b1 domain helices of H2-M are
shifted considerably into the core of the groove.
(D) Comparison of H2-M with two nonclassical class I±like molecules. H2-M is displayed as before while CD1d1 is shown in white and FcRn
is shown in gray. The structures were superimposed using the analogous b-sheet residues used in (B). The general positions of the groove
flanking helices compare more favorably with the nonclassical MHC molecules.
b34 to switch its disulfide bonding partner. However, to be dramatically shifted relative to their classical coun-
terparts. The H2-M h2 helix has rotated nearly as a rigiddata collected from two different Hg-containing com-
pounds, which both exclusively formed derivatives with body around the pivot point of the disulfide bond be-
tween Cys a21 and Cys a76. As a result of this rotation,Cys b45 on the s4 strand, indicate that this cysteine is
free in the structure. Both potential sites for N-linked the region connecting the H22M a1 domain h1 and
h2 helices nearly superimposes on the region usuallysugars in H2-M were found to be glycosylated in the
structure. Both were on the a chain, one near the N occupied by the N-terminal amino acid residues of pep-
tides bound to either class I or class II. It is worth notingterminus and the other in the a2 domain at the end of
the E b strand. that this region maintains an extended conformation
similar to that of the corresponding region in class IIWhile H2-M is similar to all MHC molecules, it is most
like class II MHC. Figure 1B shows a superimposition MHC molecules, in contrast to the helical conformation
adopted by this region in class I MHC molecules. Aof H2-M with a mouse class II MHC molecule, IEk (Fre-
mont et al., 1996). The similarity between the two struc- similar comparison is shown in Figure 1D between H2-M
and two nonclassical class lb MHC molecules, CD1d1tures is striking not only in the alignment of the core b
strands within each domain but also in overall quater- (Zeng et al., 1997) and the rat neonatal Fc receptor
(FcRn) (Burmeister et al., 1994). Again, the b strandsnary structure. The greatest differences occur in the
loops and a helices flanking the classical antigen-bind- superimpose very well. In this case, the differences be-
tween these molecules and H2-M in the a helices areing groove. These differences are better seen in Figure
1C, which shows a backbone trace view of the a1/b1 less dramatic. Although most of the helical segments of
H2-M align better with these nonclassical MHC mole-domains of H2-M compared to the corresponding do-
mains of a representative class Ia MHC molecule, Kb cules, the h2 segment of the H2-M a1 domain sits closer
to the center of the groove while the h2a segment of(Fremont et al., 1992), and the class II MHC molecule,
IEk. The platform b strands of the molecules superim- the H2-M b1 domain is shifted away from the center.
The family of MHC and MHC-like proteins has evolvedpose well, but segments of the H2-M a helices are seen
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Figure 2. Conserved Structural Elements
among H2-M and Other MHC Molecules
The sequence of a1a2/b1b2 domains of the
ab2 H2-M used in these studies is aligned
with those of the H2-M b1 chain (Karlsson et
al., 1994), the a and b chain of HLA-DM (Kelly
and Trowsdale, 1994), and four other MHC
molecules: IEk (Fremont et al., 1996), Kb (Fre-
mont et al., 1992), CD1d1 (Zeng et al., 1997),
and FcRn (Burmeister et al., 1994). For the
H2-M/HLA-DM sequences amino acids iden-
tical to ab2 H2-M are indicated by black dots.
For the other molecules, the alignment is
based on direct superimposition of the coor-
dinates, rather than sequence homology (In-
sight/Homology, Biosym). Shaded areas rep-
resent a helices and b strands (Kabsch and
Sander, 1983), except for the D strands that
are mostly extended strands rather than b
strands in these structures. The b strandsand
a-helical segments for H2-M are also indi-
cated graphically. Numbering is based on the
ab2 H2-M sequence, starting from the a and
b chain N termini determined by protein se-
quencing.
to perform a number of functions in addition to presenta- the involvement of the C and N termini of the peptide
in binding by class I MHC. For H2-M, CD1d1, and FcRn,tion of conventional peptide antigens to T cells. Some
have developed the ability to present specialized anti- the narrowing of the binding pocket is apparent. The
binding pocket of FcRn is completely occluded, i.e.,gens. For example, the class Ib MHC molecule, H2-M3,
has become specific for the presentation of peptides none of the b strands of the floor are visible from this
view. The CD1d1 binding pocket is narrowed, but a largecontaining a formylated methionine at the N terminus,
such as peptides derived from the N terminus of many groove is still visible and is lined almost entirely with
hydrophobic amino acids, reflecting the ability of thisbacterial proteins (Smith et al., 1994). The CD1d1 mole-
cule has the ability to present glycolipids and perhaps molecule to bind glycolipids and present them to T cells.
H2-M lies in between these two MHC-like molecules.special hydrophobic peptides (Castano et al., 1995;
Joyce et al., 1998). FcRn transcytoses milk-borne immu- The binding groove is greatly narrowed so as to prevent
conventional peptide binding, but a sizable area of thenoglobulin in neonatal intestine (reviewed in Raghavan
and Bjorkman, 1996). Yet another MHC-like molecule, b strand floor is still visible, creating a single pocket
corresponding to the P4 pocket of class II MHC mole-HFE, the product of the hemochromatosis gene, is in-
volved in iron storage (Cuthbert, 1997; Lebron et al., cules. We have termed this pocket P49. The base of the
P49 pocket is centered around H2-M Ser b8 and is1998).
H2-M and these MHC-like molecules all share a com- formed by a number of residues with diverse chemical
properties contributed from the platform and helicesmon structure, with many conserved features among
them. Figure 2 shows the sequences of a number of (see Figure 3 legend). Extra electron density found in
this pocket has been difficult to interpret due to theMHC molecules aligned by their common structural ele-
ments as determined crystallographically. Despite the limited resolution of the current structure. The role of the
P49 pocket in H2-M function remains to be determined.often great divergence in amino acid sequence, the core
b strand and a-helical structural elements of these mole-
cules are all present. Still, each carries unique features, Possible Functional Sites on H2-M
The molecular mechanism by which H2-M and HLA-DMespecially in the region that forms the peptide-binding
groove in conventional MHC molecules. This lack of facilitate the exchange of class II±bound CLIP with other
peptides is unknown. The interaction of these moleculesconservation of residues that line the groove and the
significant shifts in the helical segments of H2-M relative apparently involves the region around class II MHC
amino acid a96, since a mutation in HLA-DR3 introduc-to the conventional MHC support the conclusion that
H-2M does not bind peptides in a classical manner. ing a glycosylation site at this position prevents HLA-
DM function (Sanderson et al., 1996; Guerra et al., 1998).These differences in the binding groove are best seen
in Figure 3, which shows space-filling top views of the As of yet, no site-specific mutagenesis experiments
have been performed on H2-M (or HLA-DM) to definemembrane distal regions of H2-M, IEk, IAk, Kb, CD1d1,
and FcRn. Among the three peptide-binding molecules, the sites of interaction. Unfortunately, the structure of
H2-M does not reveal anyfeature that obviously explainsthe spacing between the a helices leaves the b strand
floor of the binding groove clearly visible from this point its function. However, several studies have shown that
human HLA-DM can function with mouse class II MHC,of view. Typical of class II MHC, the ends of the groove
are open in IEk and IAk, allowing the ends of longer and vice versa (Brooks et al., 1994; Karlsson et al., 1994;
Albert et al., 1996). Furthermore, H2-M, unlike HLA-DM,peptides to extend. The ends of Kb are closed, reflecting
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Figure 3. Binding Groove Comparisons
The membrane distal domains of H2-M, IEk
(Fremont et al., 1996), IAk (Fremont et al.,
1998), H2-Kb (Fremont et al., 1992), CD1d1
(Zeng et al., 1997), and FcRn (Burmeister et
al., 1994) are displayed as CPK models (Car-
son, 1987). The a1 domain helices are shown
in cyan, with the class II b1domains and class
I a2 domains shown in magenta, each labeled
at their amino-terminal regions. The eight-
stranded b-sheet platforms for each mole-
cule are displayed in yellow. The defined pep-
tide-binding pockets of the class I and class
II MHC molecules are labeled by standard
conventions, as is the large hydrophobic cav-
ityof CD1d1 (Zeng et al., 1997). Apparent from
thecomparison is the relativelyclosed groove
of H2-M compared to the antigen-presenting
MHC molecules, with the exception of the
large cavity in the middle of the helical span.
This pocket in H2-M is termed P49 based on
its proximal similarity to the P4 pocket found
in class II MHC molecules. The following
amino acids contribute to the lining of the P49
pocket: a chainÐPhe a15, His a17 Glu a32,
Arg a49 and Gln a63 to Asp a72; b chain
residuesÐSer b8, Cys b10, Phe b 21, Tyr b23,
Trp b35 and Leu b67 to His b81. The two
a-helical regions of H2-M bury a total of 750
AÊ 2 of surface area between each other, calcu-
lated for a53-a92 and b45-b91 using a 1.4 AÊ
probe (Connolly, 1993). The analogous a-heli-
cal regions of I-Ek bury 454 AÊ 2, IAk buries 516
AÊ 2, H2-Kb buries 627 AÊ 2, and CD1d1 buries 377
AÊ 2. The a-helical regions of the non-antigen-
presenting FcRn are considerablymore closely
packed, with 1259 AÊ 2 buried between them.
has two alternative b chains, b1 and b2 (Peleraux et al., Other surface features of H2-M may help explain the
sensitivity of H2-M/HLA-DM to pH. The binding of H2-1996), although the b2 chain seems to be predominant
in the expressed molecule (Karlsson et al., 1994). There- M/HLA-DM to class II MHC and its ability to facilitate
peptide exchange is enhanced at the low pH (z5) offore, we compared the sequences of these molecules
for areas of variability and conservation (Figures 2 and the endosomes (Sloan et al., 1995; Denzin et al., 1996;
Sanderson et al., 1996). H2-O/HLA-DO influences on H2-4A) with the idea that the conserved regions should
contain the functional sites, while highly variable regions M/HLA-DM function are also regulated by pH (Liljedahl
et al., 1998). In our studies, H2-M remained soluble toprobably do not.
The most highly variable areas of the molecular sur- high concentration at pH 7. At pH 5.5, solubility was
lowered dramatically and crystal formation occurredfaces are exposed on the tops of the a helices. The
nonconserved amino acids argue against an extensive within minutes at physiological ionic strengths. One
study of HLA-DM showed an increase in binding sitesinteraction site on that face. A number of conserved
features that may relate to the function of these mole- for a hydrophobic dye when the pH was lowered from 7
to 5.5 (Ullrich et al.,1997). Taken together, these findingscules are highlighted in Figures 4A and 4B. Most resi-
dues along the interaction face between the helices are suggest the presence of acidic groups on the surface
of H2-M/HLA-DM (and perhaps of class II MHC as well)conserved, making it unlikely that a large groove exists
in any of these three molecules. This argues against that must be protonated before these molecules can
interact with class II MHC or themselves.conventional peptide binding to H2-M, although it does
not eliminate the possibility of a nonconventional pep- This view is consistent with the highly acidic surface
of H2-M (Figure 4B), which appears to be conservedtide-binding site, possibly involving the residual P49
pocket. The residues composing the base of the P49 on HLA2DM. While most of this negative potential is
evenly distributed on the surface, there are some con-pocket are highly conserved, although the rim around
the pocket does vary (Figure 4A). Nevertheless, this re- centrated patches. For example, the underside of the
H2-M b strand platform has a large number of exposedgion could play a role in the interaction of H2-M with
class II MHC, Ii, or H2-O. acidic residues. Several of these are conserved in class
Immunity
390
Figure 4. Surface Features of H2-M
(A) A molecular surface image (GRASP; Ni-
cholls et al., 1991) of H2-M color-coded by
sequence variation among H2-M ab2, H2-M
ab1, and HLA-DM (Figure 2). The view is from
the top of the a-helical regions. Residues that
are invariant among all three molecules are
gray. Those that differ between H2-M ab2 and
HLA-DM butnot betweenH2-M ab2 and H-2M
ab1 are green. Those that differ between
H2-M ab2 and H22M ab1 but not between
H2-M ab2 and HLA-DR are light yellow. Fi-
nally, those that differ among all three mole-
cules are bright yellow. Individual domains
are labeled and special features are demar-
cated. Notable in this view is the P49 pocket,
which is lined with conserved residues but
which is somewhat variable around its edges.
The region around the classic P1 pocket is
remarkably conserved however. Also indi-
cated is a hydrophobic seam located be-
tween the a1 domain h2 helix and b1 domain
h1 helix near the classic P6 and P9 pockets. At the edge of this region is a potential N-linked glycosylation site found in H2M b1 but not b2.
(B) Side view of H2-M with the b2 domain in front and the a helices tipped forward. The electrostatic surface was calculated using standard
conventions (Nicholls et al., 1991). The surface is colored according to the local electrostatic potential, with negative in red and positive in
blue. The highly acidic character of the surface is evident. Several conserved surface features are labeled. A solvent accessible hydrophobic
ledge is formed primarily by the s4 strand of the H2-M b1 domain and its connection to the h1 a helix. This ledge lies adjacent to a cluster
of three exposed cysteines. This area is flanked by a number of acidic residues (b7, b30, b36, and b46). Another acidic cluster is formed by
adjacent acidic residues on the loop between the a1 s2 and s3 strands (a35-a37) and one at the end of the a2 D strand (a151). These residues
form part of a contact region between the a1 and a2 domains. Underlining indicates acidic residues that are conserved in H2-M ab2, H2-
Mab1, and HLA-DM, but not in class II MHC.
II MHC, but the acidic character of positions a36, b7, homodimer formation (Brown et al., 1993). Adjacent to
this region is an exposed cluster of cysteine residues,and b46 is unique to H2-M and HLA-DM. Protonation
of these acidic clusters could lead to a conformational unique to H2-M/HLA-DM molecules. It is tempting to
speculate that the surrounding strongly negative elec-change in the H2-M and/or class II MHC uncovering new
sites for interaction. Alternatively, lowering the negative trostatic potential may protect this type of otherwise
hydrophobic surface from improper engagement untilcharge on the surfaces of H2-M and class II MHC may
be needed simply to overcome the charge repulsion the molecule has trafficked into the low pH environment
of the proper endosomal compartment.between them, allowing association to occur.
Several studies have suggested the involvement of Clearly, further mutational and structural research will
be necessary to understand how H2-M carries out itshydrophobic regions on H2-M/HLA2DM in their interac-
tion with class II MHC. In one experiment, binding of a function. It is hoped that the structure described here
will provide a framework for the rational design of thesehydrophobic dye was reduced after the interaction of
HLA-DM with human HLA-DR at low pH (Ullrich et al., future studies.
1997). This finding suggested that hydrophobic regions
of HLA-DM and/or HLA-DR became buried at their inter-
Experimental Procedures
face. Still other experiments have shown the enhance-
ment of HLA-DM activity by neutral detergents (Sloan Expression of the Genes Encoding H2-M
et al., 1995; Sanderson et al., 1996) and the enhance- Portions of the H2-M genes encoding the predicted extracellular
a1/a2 and b1/b2 domains of the a and b2 chains, respectively, werement of CLIP release from HLA-DR by short chain, neu-
synthesized by PCR. Total C57BL/10 splenic cDNA was used as atral detergents (Avva and Cresswell, 1994).
template, and oligonucleotides were designed to allow cloning intoPerhaps relevant to these findings are several hy-
a previously described (Kappler et al., 1994; Kozono et al., 1994)
drophobic regions seen on the surface of H2-M. For baculovirus transfer vector (Figure 5A). The PstI/SphI a chain gene
example, there is an exposed hydrophobic seam be- fragment was cloned in frame with sequence encoding a mouse
tween the a and b chain helices in the region normally abTCR Vb5/8 leader behind the baculovirus polyhedrin promoter.
The SacII/KpnI b gene fragment was cloned into the same vectoroccupied by the P6 and P9 pockets of class II MHC.
in frame with an abTCR Va11 leader behind the p10 promoter. TheThe amino acids that compose this interface vary con-
recombinant genes were introduced into baculovirus using the Ba-siderably among HLA-DM and the two forms of H2-M,
culoGold system (Pharmingen) and a high-titered viral stock pre-
but the strongly hydrophobic character is maintained. pared as previously described (Kappler et al., 1994; Kozono et al.,
A second conserved hydrophobic region occurs along 1994). The intended C-terminal amino acids of the a chain were
and below a ledge created in part by the connecting WVPQ and of the b chain were WTPG.
segment between the b1 domain s4 strand and H1 helix,
a region unique in length and sequence compared to Production and Purification of Soluble H2-M
other MHC family members (Figure 2). This general re- Soluble secreted H2-M was produced by infection of High Five
insect cells (InVitrogen) with baculovirus at high multiplicity. Sincegion has been previously implicated in MHC class II
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Figure 5. Expression and Characterization of
Soluble H2-M
(A) The strategy for cloning the extracellular
domains of H2-M in a baculovirus transfer
vector is shown. The oligonucleotide primers
containing the restriction enzyme recognition
sites shown (left and right arrows) were used
in a PCR to synthesize sequence encoding
the extracellular domains of H2-M. The frag-
ments were then cloned in frame with se-
quence encoding abTCR leader peptides for
expression in baculovirus. See the Results
and Discussion and Experimental Proce-
dures for details.
(B) Purified soluble H2-M was analyzed by
SDS-PAGE, isoelectric focusing (IEF), and na-
tive PAGE using the Phast system (Phar-
macia). 0.5±1.0 mg of H2-M were loaded in
each lane. SDS-PAGE molecular weight and
native PAGE standards were from Pharmacia.
IEF standards were from Sigma.
concanavalin A (ConA) chromatography was to be used in the purifi- soluble H2-M purified as above. The overall yield was similar in the
two methods. Amino acid analysis (Protein Core Facility, Howardcation, infection was performed in a serum-free modified CCM3
medium from which the usual yeastolate additive was omitted Hughes Medical Institute/Columbia University) indicated a very high
substitution of SeMet for methionine in the purified protein as indi-(HyClone Labs). At 6 days post infection, the culture supernatant
was collected and glycoproteins isolated by passage over a ConA cated by an z95% loss of methionine.
Sepharose 4B (Sigma Chem. Co.). The bound protein was eluted
with 250 mM Methyl a-D-Manno-pyranoside (Sigma). Gel analysis Crystallization and Derivation of H2-M
Initially, ill-formed crystals of H2-M grew spontaneously at 208C inof the eluate suggested H2-M was the dominant protein after this
step. The concentrated eluate was subjected to size exclusion chro- hanging drops in a mother liquor consisting of 400 mM (NH4)2SO4
and 0.1 M MES (pH 6.5). To produce diffraction grade crystals ofmatography on Superdex-200 and fractions containing the major
peak, (which emerged at a position corresponding to a molecular native H2-M, a limiting dilution of homogenized micro-crystals was
used to seed 3±6 ml drops containing 5±7 mg/ml H2-M, 50 mMweight of z50 kDa), were pooled and subjected to FPLC anion
exchange chromatography using Mono-Q resin. Fractions con- Li2SO4, and 50 mM MES (pH 5.5). The drops were allowed to concen-
trate 2-fold at 48C over a mother liquor of 100 mM Li2SO4 and 100taining the major peak were pooled, exchanged into buffer con-
taining 10 mM HEPES (pH 7.0) and 5 mM NaN3, and concentrated mM MES (pH 5.5). 1±3 tetragonal crystals with dimensions of about
0.2 3 0.6 3 0.6 mm grew over a period of 2±5 days. A similar seedingto about 10 mg/ml. The protein was stored at 48C. Overall yield was
about 1±2 mg/liter of culture supernatant. N-terminal sequencing technique was used to produce crystals with the SeMet substituted
H2-M. For preparing heavy metal derivatives, crystals were trans-(National Jewish Biomolecular Resource Facility) of the protein con-
firmed that it was indeed H2-M and established the N-terminal se- ferred at least several days before data collection to new drops
containing 2±3 mg/ml H2-M (to prevent dissolution of the crystal),quence as ASTPVF for the a chain (3 amino acids shorter than
previously predicted) and GFVAHV for the b2 chain. 100 mM Li2SO4, 100 mM MES (pH 5.5), and either 10- to 20-fold
molar excess Thimerosal (Sigma Chemical Co.), 10- to 20-fold molarThe final product was subjected to SDS-PAGE, isoelectric focus-
ing, and native PAGE (Figure 5B). A nearly homogeneous protein excess ethyl mercury chloride (Alfaásar), or 1- to 2-fold molar ex-
cess K2PtCl4 (Aldrich Chem. Co.).was seen with all three techniques. Although both the a and b chain
are of the same length, the higher molecular weight of the a chain
on SDS-PAGE reflected the presence of two N-linked carbohydrates Structure Determination
All data were collected at room temperature with a Rigaku rotatingversus none in the b chain. The protein exhibited a very low pI of
4.5, reflecting the high frequency of acidic versus basic amino acids anode X-ray generator operating at 50 kV and 100 mA, equipped
with Yale mirrors and an R-Axis IV detector. Crystals were capillaryin its primary structure.
This protocol was modified to produce H2-M in which SeMet was mounted and one degree oscillations were collected (Table 1). The
data were autoindexed and processed with DENZO and then scaledsubstituted for methionine. Initial viral infection was performed in
the modified CCM3 medium described above. At 24 hr after infec- and merged using SCALEPACK (Otwinowski and Minor, 1997). The
crystals belonged to space group I4 with unit dimensions a 5 b 5tion, the insects cells were harvested, washed, and transferred to
serum-free modified CCM3 medium lacking yeastolate and methio- 142.7 AÊ and c 5 76.9 AÊ , with one H2-M heterodimer per asymmetric
unit and a solvent content of approximately 70%. Average mosaicitynine (HyClone Labs) and supplemented with 50 mg/ml SeMet
(Sigma). Culture supernatant was harvested after 6 days and the was about 0.3 degrees. The 3.1 AÊ native data set was derived from
Immunity
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the merging of data from four different crystals. Attempts to cryo- Brooks, A.G., Campbell, P.L., Reynolds, P., Gautam, A.M., and
McCluskey, J. (1994). Antigen presentation and assembly by mousepreserve the crystals using a wide variety of cryo-protectants failed,
possibly due to the high solvent content of the crystals. I-Ak class II molecules in human APC containing deleted or mutated
HLA DM genes. J. Immunol. 153, 5382±5392.Initial phases for the H2-M structure were obtained by molecular
replacement (MR) using AMoRE (Collaborative Computational Proj- Brown, J.H., Jardetzky, T.S., Gorga, J.C., Stern, L.J., Urban, R.G.,
ect, 1994). Coordinates of IEk (PDB accession code 1IEA; Fremont Strominger, J.L., andWiley, D.C. (1993). Three-dimensional structure
et al., 1996) with truncated loops and mismatched side-chains were of the human class II histocompatibility antigen HLA-DR1. Nature
used as a model, providing unambiguous rotation and translation 364, 33±39.
function solutions. The rigid body refined model gave an R factor of Brunger, A.T., Kuriyan, J., and Karplus, M. (1987). Crystallographic
49.3% and correlation coefficient of 26.5% for 8±4 AÊ data. However, R-factor refinement by molecular dynamics. Science 235, 458±460.
electron density maps calculated from MR phases were not readily
Burmeister, W.P., Gastinel, L.N., Simister, N.E., Blum, M.L., andinterpretable. We therefore collected a number of data sets using
Bjorkman, P.J. (1994). Crystal structure at 2.2 A resolution of theseveral heavy atom derivatives of the crystals (Table 1), with heavy
MHC-related neonatal Fc receptor. Nature 372, 336±343.atom positions easily found by difference Fourier analysis. The two
Busch, R., and Mellins, E.D. (1996). Developing and shedding inhibi-mercury compounds were both found near the solvent exposed Cys
tions: how class II MHC molecules reach maturity. Curr. Opin. Immu-b45 while the platinum compound formed a derivative with Met
nol. 8, 51±58.b131. Selenomethionine substitution resulted in difference peaks at
all four methionines present in the molecule, as well as, inexplicably, Carson, M. (1987). Ribbon modelsof macromolecules.J. Mol. Graph.
Cys b45. MIR electron density maps calculated with MLPHARE 5, 103±106.
(Collaborative Computational Project, 1994) were difficult to inter- Castano, A.R., Tangri, S., Miller, J.E., Holcombe, H.R., Jackson,
pret, as all of the derivatives provided poor phasing power. We M.R., Huse, W.D., Kronenberg, M., and Peterson, P.A. (1995). Pep-
therefore combined the MR and MIR phases using SIGMAA (Collab- tide binding and presentation by mouse CD1. Science 269, 223±226.
orative Computational Project, 1994) and modified the density using
Collaborative Computational Project (1994). The CCP4 suite pro-SOLOMON (Abrahams and Leslie, 1996), making use of the large
grams for protein crystallography. Acta Crystallogr. D 50, 760±763.
solvent content of the crystals. These new maps could be easily
Connolly, M.L. (1993). The molecularsurface package. J. Mol. Graph.traced, although the electron densities for many side-chains were
11, 139±141.of poor quality. Superior quality electron density maps were ob-
Copier, J., Kleijmeer, M.J., Ponnambalam, S., Oorschot, V., Potter,tained after numerous cycles of model building using a modified
P., Trowsdale, J., and Kelly, A. (1996). Targeting signal and subcellu-version of TOM(Jones, 1978), least squares and simulated annealing
lar compartments involved in the intracellular trafficking of HLA-atomic refinement using XPLOR (Brunger et al., 1987), and phase
DMB. J. Immunol. 157, 1017±1027.combination using SIGMAA and SOLOMON.
The final model is comprised of 371 amino acid residues (H2-Mb Cuthbert, J.A. (1997). Iron, HFE, and hemochromatosis update. J.
a chain residues a11-a191 and H2-Mb b2 chain residues b1-b190) Investig. Med. 45, 518±529.
and two GlcNAc residues attached to Asn a12 and Asn a162. No Denzin, L.K., Hammond, C., and Cresswell, P. (1996). HLA-DM inter-
solvent molecules were modeled although a bulk solvent correction actions with intermediates in HLA-DR maturation and a role for
was applied within XPLOR. Refinement of this model against all HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184,
data between 12.0 and 3.1 AÊ yielded an R value of 20.5% and an 2153±2165.
R-free of 25.6 % (5% test set) with reasonable geometry (Table 1).
Denzin, L.K., Robbins, N.F., Carboy-Newcomb, C., and Cresswell,
In the current model, 79.8% of the H2-M residues have highly fa-
P. (1994). Assembly and intracellular transport of HLA-DM and cor-
vored φ,c angles, while 1.6% (5 residues) have disallowed angles. rection of the class II antigen-processing defect in T2 cells. Immunity
1, 595±606.
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